FR2414336A1 - Nouvelles compositions pharmaceutiques a base de prostaglandines - Google Patents

Nouvelles compositions pharmaceutiques a base de prostaglandines

Info

Publication number
FR2414336A1
FR2414336A1 FR7901110A FR7901110A FR2414336A1 FR 2414336 A1 FR2414336 A1 FR 2414336A1 FR 7901110 A FR7901110 A FR 7901110A FR 7901110 A FR7901110 A FR 7901110A FR 2414336 A1 FR2414336 A1 FR 2414336A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
prostaglandins
compositions based
new pharmaceutical
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7901110A
Other languages
English (en)
Other versions
FR2414336B1 (fr
Inventor
Thomas Cavanak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2414336A1 publication Critical patent/FR2414336A1/fr
Application granted granted Critical
Publication of FR2414336B1 publication Critical patent/FR2414336B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a pour objet des compositions pharmaceutiques à base de prostaglandines. Selon l'invention, ces compositions pharmaceutiques contiennent une prostaglandine en association avec un hydrolysat hydrogéné de l'amidon et/ou des esters non-ioniques obtenus par réaction d'un triglycéride avec un polyalkylèneglycol. Ces compositions pharmaceutiques présentent une bonne stabilité.
FR7901110A 1978-01-17 1979-01-17 Nouvelles compositions pharmaceutiques a base de prostaglandines Granted FR2414336A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46378 1978-01-17

Publications (2)

Publication Number Publication Date
FR2414336A1 true FR2414336A1 (fr) 1979-08-10
FR2414336B1 FR2414336B1 (fr) 1981-07-31

Family

ID=4187587

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7901110A Granted FR2414336A1 (fr) 1978-01-17 1979-01-17 Nouvelles compositions pharmaceutiques a base de prostaglandines

Country Status (20)

Country Link
JP (1) JPS54110313A (fr)
AR (1) AR218518A1 (fr)
AU (1) AU4337979A (fr)
BE (1) BE873481A (fr)
DD (1) DD141260A5 (fr)
DE (1) DE2900428A1 (fr)
DK (1) DK7679A (fr)
ES (1) ES476857A1 (fr)
FI (1) FI790043A (fr)
FR (1) FR2414336A1 (fr)
GB (1) GB2012168A (fr)
GR (1) GR72910B (fr)
IL (1) IL56435A0 (fr)
IT (1) IT7947665A0 (fr)
NL (1) NL7900255A (fr)
NO (1) NO790059L (fr)
NZ (1) NZ189380A (fr)
PT (1) PT69073A (fr)
SE (1) SE7900124L (fr)
ZA (1) ZA79199B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024676A (en) * 1958-11-28 1962-03-13 Sack Gmbh Maschf Hydraulic presses
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
CH651756A5 (de) * 1982-02-05 1985-10-15 Sandoz Ag Pharmazeutikum in form einer suspension enthaltend thioridazin.
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPS60116628A (ja) * 1983-11-29 1985-06-24 Teijin Ltd 7−チアプロスタグランジンe↓1類製剤用組成物
JPS60169430A (ja) * 1984-02-14 1985-09-02 Teijin Ltd プロスタグランジン類製剤用組成物
JPS6191136A (ja) * 1984-10-09 1986-05-09 Teijin Ltd プロスタグランジン類製剤用組成物
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
JPH04342530A (ja) * 1991-04-26 1992-11-30 Teijin Ltd 7−フルオロプロスタサイクリン類脂肪乳剤
US8614255B2 (en) * 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations

Also Published As

Publication number Publication date
DE2900428A1 (de) 1979-07-19
ZA79199B (en) 1980-08-27
NO790059L (no) 1979-07-18
BE873481A (fr) 1979-07-16
GB2012168A (en) 1979-07-25
AR218518A1 (es) 1980-06-13
NL7900255A (nl) 1979-07-19
ES476857A1 (es) 1979-05-16
IT7947665A0 (it) 1979-01-17
DD141260A5 (de) 1980-04-23
AU4337979A (en) 1979-07-26
IL56435A0 (en) 1979-03-12
JPS54110313A (en) 1979-08-29
FI790043A (fi) 1979-07-18
SE7900124L (sv) 1979-07-18
FR2414336B1 (fr) 1981-07-31
NZ189380A (en) 1981-01-23
DK7679A (da) 1979-07-18
PT69073A (fr) 1979-02-01
GR72910B (fr) 1984-01-04

Similar Documents

Publication Publication Date Title
FR2419072A1 (fr) Nouvelles compositions pharmaceutiques a base d'un peptide monocyclique
FR2414336A1 (fr) Nouvelles compositions pharmaceutiques a base de prostaglandines
FR2423221A1 (fr) Cycloalcoyltriazoles pharmaceutiquement utilisables et procedes pour leur obtention
FR2372219A1 (fr) Compositions anti-solaires
SE8202172L (sv) Topiska farmaceutiska kompositioner
FR2293485A1 (fr) Compositions lubrifiantes ameliorees par l'addition de copolymeres greffes
FR2678637B1 (fr) Nouvelles souches de levure pour la production de xylitol.
BE785416A (fr) Compositions utiles comme succedanes de l'huile de spermaceti
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
IT7919797A0 (it) Procedimento per incrementare la fluidita' della calce.
FR2419994A1 (fr) Composition pour le traitement antiretrecissant de la laine
FR2403077A1 (fr) Preparation cosmetique contenant du tripalmitate de pyridoxine
FR2375239A1 (fr) Derives d'acide 7-amino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique
FR2405657A1 (fr) Agent favorisant la croissance des animaux
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
FR2401148A1 (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
FR2444056A1 (fr) Produits d'addition de triepoxy-hydantoines et de bis-hydantoines, et compositions durcissables de ces produits
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
FR2377804A1 (fr) Compositions analgesiques et anti-inflammatoires comprenant des derives de chromone
MA20544A1 (fr) Association synergique contraceptive
ES8600928A1 (es) Un metodo de producir un preparado de nifedipina particularmente adecuado para administracion rectal
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs
FR2305495A1 (fr) Compositions lubrifiantes ameliorant le gonflement des joints d'etancheite
FR2422404A1 (fr) Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse